{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T15:08:07Z","timestamp":1788275287842,"version":"build-2803163510"},"reference-count":181,"publisher":"MDPI AG","issue":"23","license":[{"start":{"date-parts":[[2022,11,23]],"date-time":"2022-11-23T00:00:00Z","timestamp":1669161600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"National Natural Science Foundation of China","award":["82070784"],"award-info":[{"award-number":["82070784"]}]},{"name":"National Natural Science Foundation of China","award":["81702536"],"award-info":[{"award-number":["81702536"]}]},{"name":"National Natural Science Foundation of China","award":["2022JDRC0040"],"award-info":[{"award-number":["2022JDRC0040"]}]},{"name":"Science &amp; Technology Department of Sichuan Province, China","award":["82070784"],"award-info":[{"award-number":["82070784"]}]},{"name":"Science &amp; Technology Department of Sichuan Province, China","award":["81702536"],"award-info":[{"award-number":["81702536"]}]},{"name":"Science &amp; Technology Department of Sichuan Province, China","award":["2022JDRC0040"],"award-info":[{"award-number":["2022JDRC0040"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Interstitial cystitis\/bladder pain syndrome (IC\/BPS) is a debilitating disease that induces mental stress, lower urinary symptoms, and pelvic pain, therefore resulting in a decline in quality of life. The present diagnoses and treatments still lead to unsatisfactory outcomes, and novel diagnostic and therapeutic modalities are needed. Although our understanding of the etiology and pathophysiology of IC\/BPS is growing, the altered permeability of the impaired urothelium, the sensitized nerves on the bladder wall, and the chronic or intermittent sensory pain with inaccurate location, as well as pathologic angiogenesis, fibrosis, and Hunner lesions, all act as barriers to better diagnoses and treatments. This study aimed to summarize the comprehensive information on IC\/BPS research, thereby promoting the progress of IC\/BPS in the aspects of diagnosis, treatment, and prognosis. According to diverse international guidelines, the etiology of IC\/BPS is associated with multiple factors, while the presence of Hunner lesions could largely distinguish the pathology, diagnosis, and treatment of non-Hunner lesions in IC\/BPS patients. On the basis of the diagnosis of exclusion, the diverse present diagnostic and therapeutic procedures are undergoing a transition from a single approach to multimodal strategies targeting different potential phenotypes recommended by different guidelines. Investigations into the mechanisms involved in urinary symptoms, pain sensation, and bladder fibrosis indicate the pathophysiology of IC\/BPS for further potential strategies, both in diagnosis and treatment. An overview of IC\/BPS in terms of epidemiology, etiology, pathology, diagnosis, treatment, and fundamental research is provided with the latest evidence. On the basis of shared decision-making, a multimodal strategy of diagnosis and treatment targeting potential phenotypes for individual patients with IC\/BPS would be of great benefit for the entire process of management. The complexity and emerging evidence on IC\/BPS elicit more relevant studies and research and could optimize the management of IC\/BPS patients.<\/jats:p>","DOI":"10.3390\/ijms232314594","type":"journal-article","created":{"date-parts":[[2022,11,23]],"date-time":"2022-11-23T09:50:52Z","timestamp":1669197052000},"page":"14594","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":42,"title":["Broaden Horizons: The Advancement of Interstitial Cystitis\/Bladder Pain Syndrome"],"prefix":"10.3390","volume":"23","author":[{"given":"Jin","family":"Li","sequence":"first","affiliation":[{"name":"West China School of Medicine, Sichuan University, Chengdu 610041, China"},{"name":"Department of Urology, Institute of Urology, Sichuan University, Chengdu 610041, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianyanling","family":"Yi","sequence":"additional","affiliation":[{"name":"West China School of Medicine, Sichuan University, Chengdu 610041, China"},{"name":"Department of Urology, Institute of Urology, Sichuan University, Chengdu 610041, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0617-9286","authenticated-orcid":false,"given":"Jianzhong","family":"Ai","sequence":"additional","affiliation":[{"name":"Department of Urology, Institute of Urology, Sichuan University, Chengdu 610041, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,11,23]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1097\/JU.0000000000002756","article-title":"Diagnosis and Treatment of Interstitial Cystitis\/Bladder Pain Syndrome","volume":"208","author":"Clemens","year":"2022","journal-title":"J. Urol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1016\/j.juro.2015.01.086","article-title":"Diagnosis and Treatment of Interstitial Cystitis\/Bladder Pain Syndrome: AUA Guideline Amendment","volume":"193","author":"Hanno","year":"2015","journal-title":"J. Urol."},{"key":"ref_3","unstructured":"Engeler, D., Baranowski, A.P., Berghmans, B., Birch, J., Borovicka, J., and Cottrell, A.M. (2022, January 1\u20134). EAU Guidelines on Chronic Pelvic Pain. Proceedings of the EAU Annual Congress Amsterdam 2022, Amsterdam, The Netherlands."},{"key":"ref_4","first-page":"S71","article-title":"How can we improve the diagnosis and management of bladder pain syndrome? Part 2: ICI-RS 2018","volume":"38","author":"Khullar","year":"2019","journal-title":"Neurourol. Urodyn."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/iju.13969","article-title":"Phenotyping of interstitial cystitis\/bladder pain syndrome","volume":"26","author":"Akiyama","year":"2019","journal-title":"Int. J. Urol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1097\/JU.0000000000001031","article-title":"Hunner Lesion Phenotype in Interstitial Cystitis\/Bladder Pain Syndrome: A Systematic Review and Meta-Analysis","volume":"204","author":"Lai","year":"2020","journal-title":"J. Urol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.1016\/j.juro.2011.03.064","article-title":"AUA Guideline for the Diagnosis and Treatment of Interstitial Cystitis\/Bladder Pain Syndrome","volume":"185","author":"Hanno","year":"2011","journal-title":"J. Urol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"E136","DOI":"10.5489\/cuaj.3786","article-title":"CUA guideline: Diagnosis and treatment of interstitial cystitis\/bladder pain syndrome","volume":"10","author":"Cox","year":"2016","journal-title":"Can. Urol. Assoc. J."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.urology.2008.09.074","article-title":"Clinical Phenotyping of Patients with Chronic Prostatitis\/Chronic Pelvic Pain Syndrome and Correlation with Symptom Severity","volume":"73","author":"Shoskes","year":"2009","journal-title":"Urology"},{"key":"ref_10","first-page":"9250","article-title":"Improving the utility of clinical phenotyping in interstitial cystitis\/painful bladder syndrome: From UPOINT to INPUT","volume":"25","author":"Crane","year":"2018","journal-title":"Can. J. Urol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1111\/iju.14234","article-title":"Clinical guidelines for interstitial cystitis\/bladder pain syndrome","volume":"27","author":"Homma","year":"2020","journal-title":"Int. J. Urol."},{"key":"ref_12","first-page":"e46","article-title":"Management of Bladder Pain Syndrome: Green-top Guideline No. 70","volume":"124","author":"Tirlapur","year":"2017","journal-title":"BJOG"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"111773","DOI":"10.1016\/j.msec.2020.111773","article-title":"Stereolithography (SLA) 3D printing of a bladder device for intravesical drug delivery","volume":"120","author":"Xu","year":"2021","journal-title":"Mater. Sci. Eng. C-Mater."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1080\/14656566.2018.1491968","article-title":"An evaluation of the pharmacotherapy for interstitial cystitis","volume":"19","author":"Giusto","year":"2018","journal-title":"Expert Opin. Pharmacother."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1039\/D0TB02094J","article-title":"Biomaterial-assisted drug delivery for interstitial cystitis\/bladder pain syndrome treatment","volume":"9","author":"Lin","year":"2021","journal-title":"J. Mater. Chem. B"},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Sarfraz, M., Qamar, S., Rehman, M.U., Tahir, M.A., Ijaz, M., Ahsan, A., Asim, M.H., and Nazir, I. (2022). Nano-Formulation Based Intravesical Drug Delivery Systems: An Overview of Versatile Approaches to Improve Urinary Bladder Diseases. Pharmaceutics, 14.","DOI":"10.3390\/pharmaceutics14091909"},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Jhang, J.F., Hsu, Y.H., Ho, H.C., Jiang, Y.H., Lee, C.L., Yu, W.R., and Kuo, H.C. (2021). Possible Association between Bladder Wall Morphological Changes on Computed Tomography and Bladder-Centered Interstitial Cystitis\/Bladder Pain Syndrome. Biomedicines, 9.","DOI":"10.3390\/biomedicines9101306"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.juro.2013.06.038","article-title":"A randomized, double-blind, placebo controlled trial of adalimumab for interstitial cystitis\/bladder pain syndrome","volume":"191","author":"Bosch","year":"2014","journal-title":"J. Urol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1007\/s00192-020-04659-w","article-title":"Efficacy and safety comparison of pharmacotherapies for interstitial cystitis and bladder pain syndrome: A systematic review and Bayesian network meta-analysis","volume":"32","author":"Di","year":"2021","journal-title":"Int. Urogynecol. J."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1016\/j.juro.2015.10.178","article-title":"Tanezumab Reduces Pain in Women with Interstitial Cystitis\/Bladder Pain Syndrome and Patients with Nonurological Associated Somatic Syndromes","volume":"195","author":"Nickel","year":"2016","journal-title":"J. Urol."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Wang, H., Russell, L.J., Kelly, K.M., Wang, S., and Thipphawong, J. (2017). Fulranumab in patients with interstitial cystitis\/bladder pain syndrome: Observations from a randomized, double-blind, placebo-controlled study. BMC Urol., 17.","DOI":"10.1186\/s12894-016-0193-z"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11934-015-0563-1","article-title":"Stem Cell Therapy for Interstitial Cystitis\/Bladder Pain Syndrome","volume":"17","author":"Kim","year":"2016","journal-title":"Curr. Urol. Rep."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1093\/stcltm\/szac065","article-title":"Safety of Human Embryonic Stem Cell-derived Mesenchymal Stem Cells for Treating Interstitial Cystitis: A Phase I Study","volume":"11","author":"Shin","year":"2022","journal-title":"Stem Cells Transl. Med."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1016\/j.juro.2009.12.103","article-title":"Development, validation and testing of an epidemiological case definition of interstitial cystitis\/painful bladder syndrome","volume":"183","author":"Berry","year":"2010","journal-title":"J. Urol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.juro.2011.10.040","article-title":"Comparison of an interstitial cystitis\/bladder pain syndrome clinical cohort with symptomatic community women from the RAND Interstitial Cystitis Epidemiology study","volume":"187","author":"Konkle","year":"2012","journal-title":"J. Urol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1007\/s00192-018-3574-x","article-title":"Morbidity rate and medical utilization in interstitial cystitis\/painful bladder syndrome","volume":"29","author":"Lee","year":"2018","journal-title":"Int. Urogynecol. J."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1097\/01.ju.0000165452.39125.98","article-title":"Prevalence of clinically confirmed interstitial cystitis in women: A population based study in Finland","volume":"174","author":"Leppilahti","year":"2005","journal-title":"J. Urol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/j.eururo.2006.08.028","article-title":"Prevalence and correlates for interstitial cystitis symptoms in women participating in a health screening project","volume":"51","author":"Temml","year":"2007","journal-title":"Eur. Urol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1016\/j.juro.2006.11.084","article-title":"Prevalence of painful bladder symptoms and effect on quality of life in black, Hispanic and white men and women","volume":"177","author":"Clemens","year":"2007","journal-title":"J. Urol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1046\/j.1464-410X.2000.00855.x","article-title":"Interstitial cystitis in Japan","volume":"86","author":"Ito","year":"2000","journal-title":"BJU Int."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1002\/nau.20513","article-title":"Prevalence and correlates of painful bladder syndrome symptoms in Fuzhou Chinese women","volume":"28","author":"Song","year":"2009","journal-title":"Neurourol. Urodyn."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1111\/j.1464-410X.2011.10481.x","article-title":"Symptom profile variability of interstitial cystitis\/painful bladder syndrome by age","volume":"109","author":"Friedlander","year":"2012","journal-title":"BJU Int."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1097\/01.ju.0000165170.43617.be","article-title":"Prevalence of interstitial cystitis symptoms in a managed care population","volume":"174","author":"Clemens","year":"2005","journal-title":"J. Urol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/j.urology.2007.11.154","article-title":"Costs of interstitial cystitis in a managed care population","volume":"71","author":"Clemens","year":"2008","journal-title":"Urology"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1038\/s41585-018-0135-5","article-title":"Urologic chronic pelvic pain syndrome: Insights from the MAPP Research Network","volume":"16","author":"Clemens","year":"2019","journal-title":"Nat. Rev. Urol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s11916-020-00857-9","article-title":"A Comprehensive Review of the Diagnosis, Treatment, and Management of Urologic Chronic Pelvic Pain Syndrome","volume":"24","author":"Adamian","year":"2020","journal-title":"Curr. Pain Headache Rep."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1517\/14728214.2015.1105216","article-title":"Current and emerging drugs for interstitial cystitis\/bladder pain syndrome (IC\/BPS)","volume":"20","author":"Ogawa","year":"2015","journal-title":"Expert Opin. Emerg. Drugs"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"13","DOI":"10.5213\/inj.1632522.261","article-title":"Update on the Pathology and Diagnosis of Interstitial Cystitis\/Bladder Pain Syndrome: A Review","volume":"20","author":"Kim","year":"2016","journal-title":"Int. Neurourol. J."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1097\/01.ju.0000137953.49304.6c","article-title":"Comorbidity of interstitial cystitis with other unexplained clinical conditions","volume":"172","author":"Buffington","year":"2004","journal-title":"J. Urol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/S0022-5347(05)65984-8","article-title":"Nonbladder related symptoms in patients with interstitial cystitis","volume":"166","author":"Erickson","year":"2001","journal-title":"J. Urol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.urology.2008.06.031","article-title":"Antecedent nonbladder syndromes in case-control study of interstitial cystitis\/painful bladder syndrome","volume":"73","author":"Warren","year":"2009","journal-title":"Urology"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/iju.12325","article-title":"Interstitial cystitis is bladder pain syndrome with Hunner\u2019s lesion","volume":"21","author":"Fall","year":"2014","journal-title":"Int. J. Urol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1097\/JU.0000000000000234","article-title":"Molecular Taxonomy of Interstitial Cystitis\/Bladder Pain Syndrome Based on Whole Transcriptome Profiling by Next-Generation RNA Sequencing of Bladder Mucosal Biopsies","volume":"202","author":"Akiyama","year":"2019","journal-title":"J. Urol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1111\/iju.13971","article-title":"Hunner lesion versus non-Hunner lesion interstitial cystitis\/bladder pain syndrome","volume":"26","author":"Whitmore","year":"2019","journal-title":"Int. J. Urol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.eururo.2007.09.019","article-title":"Diagnostic criteria, classification, and nomenclature for painful bladder syndrome\/interstitial cystitis: An ESSIC proposal","volume":"53","author":"Nordling","year":"2008","journal-title":"Eur. Urol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1007\/s00192-019-03970-5","article-title":"Variations in bladder pain syndrome\/interstitial cystitis (IC) definitions, pathogenesis, diagnostics and treatment: A systematic review and evaluation of national and international guidelines","volume":"30","author":"Pape","year":"2019","journal-title":"Int. Urogynecol. J."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/S0090-4295(99)80335-5","article-title":"Associations among urodynamic findings and symptoms in women enrolled in the Interstitial Cystitis Data Base (ICDB) Study","volume":"49","author":"Kirkemo","year":"1997","journal-title":"Urology"},{"key":"ref_48","first-page":"512","article-title":"Clinical presentation and treatment of bladder pain syndrome\/interstitial cystitis (BPS\/IC) in India","volume":"4","author":"Mishra","year":"2015","journal-title":"Transl. Androl. Urol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/S0090-4295(99)80333-1","article-title":"The interstitial cystitis symptom index and problem index","volume":"49","author":"Sant","year":"1997","journal-title":"Urology"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0094-0143(21)00593-0","article-title":"Measurement of symptoms of interstitial cystitis. A pilot study","volume":"21","author":"Keller","year":"1994","journal-title":"Urol. Clin. N. Am."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S0090-4295(02)01829-0","article-title":"Increased prevalence of interstitial cystitis: Previously unrecognized urologic and gynecologic cases identified using a new symptom questionnaire and intravesical potassium sensitivity","volume":"60","author":"Parsons","year":"2002","journal-title":"Urology"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.eururo.2011.10.004","article-title":"The bladder pain\/interstitial cystitis symptom score: Development, validation, and identification of a cut score","volume":"61","author":"Humphrey","year":"2012","journal-title":"Eur. Urol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.juro.2006.09.029","article-title":"Changes in urine markers and symptoms after bladder distention for interstitial cystitis","volume":"177","author":"Erickson","year":"2007","journal-title":"J. Urol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"C106","DOI":"10.1152\/ajpcell.00209.2006","article-title":"EGF and HB-EGF modulate inward potassium current in human bladder urothelial cells from normal and interstitial cystitis patients","volume":"292","author":"Sun","year":"2007","journal-title":"Am. J. Physiol.-Cell Physiol."},{"key":"ref_55","doi-asserted-by":"crossref","unstructured":"Jiang, Y.H., Liu, H.T., and Kuo, H.C. (2014). Decrease of urinary nerve growth factor but not brain-derived neurotrophic factor in patients with interstitial cystitis\/bladder pain syndrome treated with hyaluronic acid. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0091609"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1007\/s00192-019-04075-9","article-title":"Biomarkers in the diagnosis and symptom assessment of patients with bladder pain syndrome: A systematic review","volume":"30","author":"Magalhaes","year":"2019","journal-title":"Int. Urogynecol. J."},{"key":"ref_57","first-page":"25","article-title":"Interstitial cystitis and endometriosis in patients with chronic pelvic pain: The \u201cEvil Twins\u201d syndrome","volume":"9","author":"Chung","year":"2005","journal-title":"JSLS J. Soc. Laparoendosc. Surg."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/S0090-4295(01)01131-1","article-title":"Interstitial cystitis: Current issues and controversies in diagnosis","volume":"57","author":"Sant","year":"2001","journal-title":"Urology"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s00192-015-2794-6","article-title":"MRI suggests increased tonicity of the levator ani in women with interstitial cystitis\/bladder pain syndrome","volume":"27","author":"Ackerman","year":"2016","journal-title":"Int. Urogynecol. J."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1007\/s11255-018-1794-0","article-title":"Novel contrast mixture achieves contrast resolution of human bladder wall suitable for T1 mapping: Applications in interstitial cystitis and beyond","volume":"50","author":"Tyagi","year":"2018","journal-title":"Int. Urol. Nephrol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1159\/000493507","article-title":"Diffusion-Weighted Magnetic Resonance Imaging: A New Tool for the Diagnosis of Bladder Pain Syndrome\/Interstitial Cystitis","volume":"102","author":"Charlanes","year":"2019","journal-title":"Urol. Int."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1097\/01.ju.0000132411.35214.6c","article-title":"Intravesical potassium chloride sensitivity test in men with chronic pelvic pain syndrome","volume":"172","author":"Yilmaz","year":"2004","journal-title":"J. Urol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.urology.2014.03.001","article-title":"Phenotype-directed management of interstitial cystitis\/bladder pain syndrome","volume":"84","author":"Nickel","year":"2014","journal-title":"Urology"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1111\/luts.12343","article-title":"Bladder pain syndrome\/interstitial cystitis in contemporary UK practice: Outcomes of phenotype-directed management","volume":"13","author":"Neale","year":"2021","journal-title":"LUTS"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1300\/J013v31n04_05","article-title":"Pain and depression experienced by women with interstitial cystitis","volume":"31","author":"Rabin","year":"2000","journal-title":"Women Health"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1007\/s00192-016-3022-8","article-title":"Mindfulness-based stress reduction as a novel treatment for interstitial cystitis\/bladder pain syndrome: A randomized controlled trial","volume":"27","author":"Kanter","year":"2016","journal-title":"Int. Urogynecol. J."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"S175","DOI":"10.5489\/cuaj.5329","article-title":"Managing psychosocial correlates of urologic chronic pelvic pain syndromes: Advice from a urology pain psychologist","volume":"12","author":"Tripp","year":"2018","journal-title":"Can. Urol. Assoc. J."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.juro.2007.03.020","article-title":"Effect of comestibles on symptoms of interstitial cystitis","volume":"178","author":"Shorter","year":"2007","journal-title":"J. Urol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1097\/SPV.0b013e3182044b5c","article-title":"Dietary Consumption Triggers in Interstitial Cystitis\/Bladder Pain Syndrome Patients","volume":"17","author":"Bassaly","year":"2011","journal-title":"Female Pelvic Med. Reconstr. Surg."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1111\/j.1464-410X.2011.10860.x","article-title":"Diet and its role in interstitial cystitis\/bladder pain syndrome (IC\/BPS) and comorbid conditions","volume":"109","author":"Friedlander","year":"2012","journal-title":"BJU Int."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/j.urology.2004.06.065","article-title":"Modified thiele massage as therapeutic intervention for female patients with interstitial cystitis and high-tone pelvic floor dysfunction","volume":"64","author":"Oyama","year":"2004","journal-title":"Urology"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1053\/apmr.2001.24023","article-title":"Needling therapies in the management of myofascial trigger point pain: A systematic review","volume":"82","author":"Cummings","year":"2001","journal-title":"Arch. Phys. Med. Rehab."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1016\/j.juro.2012.01.123","article-title":"Randomized Multicenter Clinical Trial of Myofascial Physical Therapy in Women With Interstitial Cystitis\/Painful Bladder Syndrome and Pelvic Floor Tenderness","volume":"187","author":"FitzGerald","year":"2012","journal-title":"J. Urol."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1097\/01.ju.0000161609.31185.d5","article-title":"Integration of myofascial trigger point release and paradoxical relaxation training treatment of chronic pelvic pain in men","volume":"174","author":"Anderson","year":"2005","journal-title":"J. Urol."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1016\/S0022-5347(17)36411-X","article-title":"Behavioral therapy for the treatment of refractory interstitial cystitis","volume":"149","author":"Chaiken","year":"1993","journal-title":"J. Urol."},{"key":"ref_76","unstructured":"Partin, A.W., Dmochowski, R.R., Kavoussi, L.R., and Peters, C.A. (2021). Interstitial Cystitis\/Bladder Pain Syndrome and Related Disorders. Campbell-Walsh-Wein Urology, Elsevier. [12th ed.]."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1007\/s00192-020-04517-9","article-title":"Current status of oral pentosan polysulphate in bladder pain syndrome\/interstitial cystitis","volume":"32","author":"Taneja","year":"2021","journal-title":"Int. Urogynecol. J."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/j.juro.2014.09.036","article-title":"Pentosan Polysulfate Sodium for Treatment of Interstitial Cystitis\/Bladder Pain Syndrome: Insights from a Randomized, Double-Blind, Placebo Controlled Study","volume":"193","author":"Nickel","year":"2015","journal-title":"J. Urol."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1097\/01.ju.0000083020.06212.3d","article-title":"A pilot clinical trial of oral pentosan polysulfate and oral hydroxyzine in patients with interstitial cystitis","volume":"170","author":"Sant","year":"2003","journal-title":"J. Urol."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"365","DOI":"10.3390\/pathophysiology29030028","article-title":"Oral Preparation of Hyaluronic Acid, Chondroitin Sulfate, Curcumin, and Quercetin (Ialuril(\u00ae) Soft Gels) for the Prevention of LUTS after Intravesical Chemotherapy","volume":"29","author":"Manfredi","year":"2022","journal-title":"Pathophysiology"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1007\/s00192-019-03892-2","article-title":"Prospective comparative study of the effects of lidocaine on urodynamic and sensory parameters in bladder pain syndrome","volume":"30","author":"Offiah","year":"2019","journal-title":"Int. Urogynecol. J."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1111\/luts.12295","article-title":"Phase I study of KRP-116D, a 50% w\/w dimethyl sulfoxide aqueous solution, on the systemic absorption from bladder by intravesical instillation in healthy Japanese subjects","volume":"12","author":"Shimada","year":"2020","journal-title":"Low. Urin. Tract Symptoms"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"17562872221102809","DOI":"10.1177\/17562872221102809","article-title":"Pentosan polysulfate in patients with bladder pain syndrome\/interstitial cystitis with Hunner\u2019s lesions or glomerulations: Systematic review and meta-analysis","volume":"14","author":"Grigoryan","year":"2022","journal-title":"Ther. Adv. Urol."},{"key":"ref_84","first-page":"145","article-title":"Intravesical instillation of pentosan polysulfate encapsulated in a liposome nanocarrier for interstitial cystitis","volume":"2","author":"Lander","year":"2014","journal-title":"Am. J. Clin. Exp. Urol."},{"key":"ref_85","first-page":"270","article-title":"Assessment of long-term intravesical hyaluronic acid, chondroitin sulfate and combination therapy for patients with bladder pain syndrome","volume":"72","author":"Ozkidik","year":"2019","journal-title":"Cent. Eur. J. Urol."},{"key":"ref_86","first-page":"7739","article-title":"Heparin and alkalinized lidocaine versus alkalinized lidocaine for treatment of interstitial cystitis symptoms","volume":"22","author":"Parsons","year":"2015","journal-title":"Can. J. Urol."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1007\/s00192-012-1802-3","article-title":"Intravesical hyaluronic acid and alkalinized lidocaine for the treatment of severe painful bladder syndrome\/interstitial cystitis","volume":"23","author":"Lv","year":"2012","journal-title":"Int. Urogynecol. J."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.juro.2007.08.170","article-title":"Safety and efficacy of the use of intravesical and oral pentosan polysulfate sodium for interstitial cystitis: A randomized double-blind clinical trial","volume":"179","author":"Davis","year":"2008","journal-title":"J. Urol."},{"key":"ref_89","first-page":"206","article-title":"ESSIC criteria for the diagnosis of bladder pain syndrome\/interstitial cystitis (BPS\/IC) and comparison with the NIDDK criteria","volume":"66","author":"Proano","year":"2013","journal-title":"Arch. Esp. Urol."},{"key":"ref_90","first-page":"600","article-title":"In what type of interstitial cystitis\/bladder pain syndrome is DMSO intravesical instillation therapy effective?","volume":"4","author":"Tomoe","year":"2015","journal-title":"Transl. Androl. Urol."},{"key":"ref_91","doi-asserted-by":"crossref","unstructured":"Giannantoni, A., Gubbiotti, M., and Bini, V. (2019). Botulinum Neurotoxin A Intravesical Injections in Interstitial Cystitis\/Bladder Painful Syndrome: A Systematic Review with Meta-Analysis. Toxins, 11.","DOI":"10.3390\/toxins11090510"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.urology.2018.11.037","article-title":"Efficacy and Safety of Noninvasive Intravesical Instillation of Onabotulinum Toxin-A for Overactive Bladder and Interstitial Cystitis\/Bladder Pain Syndrome: Systematic Review and Meta-analysis","volume":"125","author":"Lee","year":"2019","journal-title":"Urology"},{"key":"ref_93","doi-asserted-by":"crossref","unstructured":"Panunzio, A., Tafuri, A., Mazzucato, G., Cerrato, C., Orlando, R., Pagliarulo, V., Antonelli, A., and Cerruto, M.A. (2022). Botulinum Toxin-A Injection in Chronic Pelvic Pain Syndrome Treatment: A Systematic Review and Pooled Meta-Analysis. Toxins, 14.","DOI":"10.3390\/toxins14010025"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/j.juro.2017.10.018","article-title":"Intratrigonal OnabotulinumtoxinA Improves Bladder Symptoms and Quality of Life in Patients with Bladder Pain Syndrome\/Interstitial Cystitis: A Pilot, Single Center, Randomized, Double-Blind, Placebo Controlled Trial","volume":"199","author":"Pinto","year":"2018","journal-title":"J. Urol."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1111\/j.1464-410X.2009.08495.x","article-title":"Comparison of intravesical botulinum toxin type A injections plus hydrodistention with hydrodistention alone for the treatment of refractory interstitial cystitis\/painful bladder syndrome","volume":"104","author":"Kuo","year":"2009","journal-title":"BJU Int."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"11031","DOI":"10.1038\/s41598-017-11062-x","article-title":"Sacral Neuromodulation for Refractory Bladder Pain Syndrome\/Interstitial Cystitis: A Global Systematic Review and Meta-analysis","volume":"7","author":"Wang","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1007\/s00192-019-03898-w","article-title":"Sacral neuromodulation treating chronic pelvic pain: A meta-analysis and systematic review of the literature","volume":"30","author":"Mahran","year":"2019","journal-title":"Int. Urogynecol. J."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/S0022-5347(05)66093-4","article-title":"Use of the neodymium: YAG laser for interstitial cystitis: A prospective study","volume":"166","author":"Rofeim","year":"2001","journal-title":"J. Urol."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"S14","DOI":"10.1080\/13697137.2019.1703940","article-title":"Effects of non-ablative vaginal erbium:YAG laser treatment for interstitial cystitis\/bladder pain syndrome: A case series (UNICORN-2 study)","volume":"23","author":"Okui","year":"2020","journal-title":"Climacteric"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"2238","DOI":"10.1016\/j.juro.2012.08.013","article-title":"Fulguration for Hunner ulcers: Long-term clinical outcomes","volume":"188","author":"Hillelsohn","year":"2012","journal-title":"J. Urol."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/j.eururo.2020.01.002","article-title":"Comparison of the Efficacy Between Transurethral Coagulation and Transurethral Resection of Hunner Lesion in Interstitial Cystitis\/Bladder Pain Syndrome Patients: A Prospective Randomized Controlled Trial","volume":"77","author":"Ko","year":"2020","journal-title":"Eur. Urol."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/s11255-020-02637-1","article-title":"Long-term outcomes of ulcerative interstitial cystitis after complete transurethral resection with therapeutic hydrodistention","volume":"53","author":"Lee","year":"2021","journal-title":"Int. Urol. Nephrol."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"284","DOI":"10.3109\/00365599.2012.669789","article-title":"Long-term experience with surgical treatment of selected patients with bladder pain syndrome\/interstitial cystitis","volume":"46","author":"Andersen","year":"2012","journal-title":"Scand. J. Urol. Nephrol."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1080\/21681805.2019.1649720","article-title":"Urinary diversion in the treatment of refractory bladder pain syndrome","volume":"53","author":"Brandt","year":"2019","journal-title":"Scand. J. Urol."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1007\/s00192-022-05110-y","article-title":"Supratrigonal cystectomy and augmentation cystoplasty with ileum or ileocecum in the treatment of ulcerative interstitial cystitis\/bladder pain syndrome: A 14-year follow-up","volume":"33","author":"Queissert","year":"2022","journal-title":"Int. Urogynecol. J."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1111\/j.1464-410X.1995.tb07668.x","article-title":"Substitution Cystoplasty for Intractable Interstitial Cystitis","volume":"76","author":"Hughes","year":"1995","journal-title":"Br. J. Urol."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/j.euf.2020.02.014","article-title":"A Systematic Review of Surgical interventions for the Treatment of Bladder Pain Syndrome\/Interstitial Cystitis","volume":"7","author":"Osman","year":"2021","journal-title":"Eur. Urol. Focus"},{"key":"ref_108","doi-asserted-by":"crossref","unstructured":"Jiang, Y.H., Peng, C.H., Liu, H.T., and Kuo, H.C. (2013). Increased pro-inflammatory cytokines, C-reactive protein and nerve growth factor expressions in serum of patients with interstitial cystitis\/bladder pain syndrome. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0076779"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1111\/j.1442-2042.2006.01373.x","article-title":"Is interstitial cystitis an allergic disorder?: A case of interstitial cystitis treated successfully with anti-IgE","volume":"13","author":"Lee","year":"2006","journal-title":"Int. J. Urol."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1002\/nau.20106","article-title":"Pilot study of the feasibility of in-office bladder distention using electromotive drug adminstration (EMDA)","volume":"24","author":"Rose","year":"2005","journal-title":"Neurourol. Urodyn."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1089\/end.1996.10.443","article-title":"Electromotive administration of intravesical lidocaine in patients with interstitial cystitis","volume":"10","author":"Gurpinar","year":"1996","journal-title":"J. Endourol."},{"key":"ref_112","doi-asserted-by":"crossref","unstructured":"Rajaganapathy, B.R., Chancellor, M.B., Nirmal, J., Dang, L., and Tyagi, P. (2015). Bladder uptake of liposomes after intravesical administration occurs by endocytosis. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0122766"},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.juro.2017.02.021","article-title":"A Prospective, Multicenter, Double-Blind, Randomized Trial of Bladder Instillation of Liposome Formulation OnabotulinumtoxinA for Interstitial Cystitis\/Bladder Pain Syndrome","volume":"198","author":"Chuang","year":"2017","journal-title":"J. Urol."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1089\/hum.2016.121","article-title":"Effect of Intravesical Liposome-Based Nerve Growth Factor Antisense Therapy on Bladder Overactivity and Nociception in a Rat Model of Cystitis Induced by Hydrogen Peroxide","volume":"28","author":"Majima","year":"2017","journal-title":"Hum. Gene Ther."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1002\/nau.20981","article-title":"Intravesical immune suppression by liposomal tacrolimus in cyclophosphamide-induced inflammatory cystitis","volume":"30","author":"Chuang","year":"2011","journal-title":"Neurourol. Urodyn."},{"key":"ref_116","first-page":"601653","article-title":"Intravesical liposome and antisense treatment for detrusor overactivity and interstitial cystitis\/painful bladder syndrome","volume":"2014","author":"Tyagi","year":"2014","journal-title":"Int. Sch. Res. Not."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.urology.2017.12.028","article-title":"Safety and Feasibility of Intravesical Instillation of Botulinum Toxin-A in Hydrogel-based Slow-release Delivery System in Patients With Interstitial Cystitis-Bladder Pain Syndrome: A Pilot Study","volume":"114","author":"Rappaport","year":"2018","journal-title":"Urology"},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"119293","DOI":"10.1016\/j.biomaterials.2019.119293","article-title":"Temperature-responsive silk-elastinlike protein polymer enhancement of intravesical drug delivery of a therapeutic glycosaminoglycan for treatment of interstitial cystitis\/painful bladder syndrome","volume":"217","author":"Jensen","year":"2019","journal-title":"Biomaterials"},{"key":"ref_119","doi-asserted-by":"crossref","unstructured":"Lin, T., Zhao, X., Zhang, Y., Lian, H., Zhuang, J., Zhang, Q., Chen, W., Wang, W., Liu, G., and Guo, S. (2016). Floating Hydrogel with Self-Generating Micro-Bubbles for Intravesical Instillation. Materials, 9.","DOI":"10.3390\/ma9121005"},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.ijpharm.2011.06.033","article-title":"Development of a mucoadhesive nanoparticulate drug delivery system for a targeted drug release in the bladder","volume":"416","author":"Barthelmes","year":"2011","journal-title":"Int. J. Pharm."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1007\/s11255-022-03280-8","article-title":"Intravesical sustained release system of lidocaine and oxybutynin results from in vitro and animal study","volume":"54","author":"Dothan","year":"2022","journal-title":"Int. Urol. Nephrol."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1080\/2090598X.2019.1605676","article-title":"Delivery of intravesical botulinum toxin A using low-energy shockwaves in the treatment of overactive bladder: A preliminary clinical study","volume":"17","author":"Nageib","year":"2019","journal-title":"Arab. J. Urol."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.ejphar.2014.02.013","article-title":"Evaluation of selective cannabinoid CB(1) and CB(2) receptor agonists in a mouse model of lipopolysaccharide-induced interstitial cystitis","volume":"729","author":"Tambaro","year":"2014","journal-title":"Eur. J. Pharmacol."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"1514.e15","DOI":"10.1016\/j.urology.2009.12.051","article-title":"Increased cannabinoid receptor 1-immunoreactive nerve fibers in overactive and painful bladder disorders and their correlation with symptoms","volume":"75","author":"Mukerji","year":"2010","journal-title":"Urology"},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"205","DOI":"10.5483\/BMBRep.2022.55.5.035","article-title":"New therapeutic approach with extracellular vesicles from stem cells for interstitial cystitis\/bladder pain syndrome","volume":"55","author":"Dayem","year":"2022","journal-title":"BMB Rep."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/s12974-022-02445-7","article-title":"Extracellular vesicles derived from mesenchymal stem cells alleviate neuroinflammation and mechanical allodynia in interstitial cystitis rats by inhibiting NLRP3 inflammasome activation","volume":"19","author":"Zhang","year":"2022","journal-title":"J. Neuroinflammation"},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1016\/j.jpain.2009.04.007","article-title":"Effects of oxytocin and prolactin on stress-induced bladder hypersensitivity in female rats","volume":"10","author":"Black","year":"2009","journal-title":"J. Pain"},{"key":"ref_128","doi-asserted-by":"crossref","unstructured":"(2007). Kca 757, Kca-757, Mn-001. Mn 001. Drugs R D, 8, 400\u2013402.","DOI":"10.2165\/00126839-200708060-00008"},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.euf.2018.06.002","article-title":"Urological Infections: \u201cThe Time for Change is Now\u201d","volume":"5","author":"Magistro","year":"2019","journal-title":"Eur. Urol. Focus"},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/j.juro.2012.05.010","article-title":"Investigation of a Ca2+ channel alpha2delta ligand for the treatment of interstitial cystitis: Results of a randomized, double-blind, placebo controlled phase II trial","volume":"188","author":"Nickel","year":"2012","journal-title":"J. Urol."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1097\/JU.0000000000000192","article-title":"Targeting the SHIP1 Pathway Fails to Show Treatment Benefit in Interstitial Cystitis\/Bladder Pain Syndrome: Lessons Learned from Evaluating Potentially Effective Therapies in This Enigmatic Syndrome","volume":"202","author":"Nickel","year":"2019","journal-title":"J. Urol."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1517\/13543784.2016.1162290","article-title":"Investigational drugs for bladder pain syndrome (BPS)\/interstitial cystitis (IC)","volume":"25","author":"Chuang","year":"2016","journal-title":"Expert Opin. Investig. Drugs"},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"122","DOI":"10.4103\/0974-7796.130553","article-title":"Chemical cystitis developed in experimental animals model: Topical effect of intravesical ozone application to bladder","volume":"6","author":"Bayrak","year":"2014","journal-title":"Urol. Ann."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.actbio.2015.02.030","article-title":"Hyaluronic acid decreases IL-6 and IL-8 secretion and permeability in an inflammatory model of interstitial cystitis","volume":"19","author":"Rooney","year":"2015","journal-title":"Acta Biomater."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1111\/j.1464-410X.2008.08097.x","article-title":"Heparin-binding epidermal growth factor-like growth factor functionally antagonizes interstitial cystitis antiproliferative factor via mitogen-activated protein kinase pathway activation","volume":"103","author":"Kim","year":"2009","journal-title":"BJU Int."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.5213\/inj.1835062.531","article-title":"Animal Modelling of Interstitial Cystitis\/Bladder Pain Syndrome","volume":"22","author":"Birder","year":"2018","journal-title":"Int. Neurourol. J."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1111\/iju.14229","article-title":"Interstitial cystitis\/bladder pain syndrome: The evolving landscape, animal models and future perspectives","volume":"27","author":"Akiyama","year":"2020","journal-title":"Int. J. Urol."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"6573","DOI":"10.1038\/s41598-018-24833-x","article-title":"Sub-noxious Intravesical Lipopolysaccharide Triggers Bladder Inflammation and Symptom Onset in A Transgenic Autoimmune Cystitis Model: A MAPP Network Animal Study","volume":"8","author":"Kogan","year":"2018","journal-title":"Sci. Rep."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1007\/s00192-018-3592-8","article-title":"Bladder wall injection of mesenchymal stem cells ameliorates bladder inflammation, overactivity, and nociception in a chemically induced interstitial cystitis-like rat model","volume":"29","author":"Furuta","year":"2018","journal-title":"Int. Urogynecol. J."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.3389\/fphar.2020.01305","article-title":"Characterization and Validation of a Chronic Model of Cyclophosphamide-Induced Interstitial Cystitis\/Bladder Pain Syndrome in Rats","volume":"11","author":"Auge","year":"2020","journal-title":"Front. Pharmacol."},{"key":"ref_141","doi-asserted-by":"crossref","unstructured":"Chen, C.H., Liao, C.H., Chen, K.C., Wang, K.L., Tseng, X.W., Tsai, W.K., Chiang, H.S., and Wu, Y.N. (2021). B6 Mouse Strain: The Best Fit for LPS-Induced Interstitial Cystitis Model. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms222112053"},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"791045","DOI":"10.3389\/fpain.2021.791045","article-title":"A Model in Female Rats With Phenotypic Features Similar to Interstitial Cystitis\/Bladder Pain Syndrome","volume":"2","author":"Ness","year":"2021","journal-title":"Front. Pain Res."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1089\/jmf.2021.K.0194","article-title":"Echinacoside Ameliorates Cyclophosphamide-Induced Bladder Damage in Mice","volume":"25","author":"Shao","year":"2022","journal-title":"J. Med. Food"},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1007\/s00192-022-05129-1","article-title":"Comorbidities of bladder pain syndrome in the context of the HITOP distress category: A systematic review and meta-analysis","volume":"33","author":"Fossing","year":"2022","journal-title":"Int. Urogynecol. J."},{"key":"ref_145","doi-asserted-by":"crossref","unstructured":"Wang, Z., Chang, H.H., Gao, Y., Zhang, R., Guo, Y., Holschneider, D.P., and Rodriguez, L.V. (2017). Effects of water avoidance stress on peripheral and central responses during bladder filling in the rat: A multidisciplinary approach to the study of urologic chronic pelvic pain syndrome (MAPP) research network study. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0182976"},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"967.e1","DOI":"10.1016\/j.urology.2011.06.041","article-title":"The effects of acute and chronic psychological stress on bladder function in a rodent model","volume":"78","author":"Smith","year":"2011","journal-title":"Urology"},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/S0022-5347(01)69129-8","article-title":"In vivo models of interstitial cystitis","volume":"167","author":"Westropp","year":"2002","journal-title":"J. Urol."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1016\/S0022-5347(05)66292-1","article-title":"Increased plasma norepinephrine concentration in cats with interstitial cystitis","volume":"165","author":"Buffington","year":"2001","journal-title":"J. Urol."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1002\/nau.20747","article-title":"Beyond neurons: Involvement of urothelial and glial cells in bladder function","volume":"29","author":"Birder","year":"2010","journal-title":"Neurourol. Urodyn."},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1007\/s10753-018-0888-2","article-title":"The Effects of Neurokinin-1 Receptor Antagonist in an Experimental Autoimmune Cystitis Model Resembling Bladder Pain Syndrome\/Interstitial Cystitis","volume":"42","author":"Liu","year":"2019","journal-title":"Inflammation"},{"key":"ref_151","doi-asserted-by":"crossref","unstructured":"Singh, U.P., Singh, N.P., Guan, H., Hegde, V.L., Price, R.L., Taub, D.D., Mishra, M.K., Nagarkatti, M., and Nagarkatti, P.S. (2013). The severity of experimental autoimmune cystitis can be ameliorated by anti-CXCL10 Ab treatment. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0079751"},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1111\/j.1464-410X.2007.07035.x","article-title":"Angiotensin II plays a role in acute murine experimental autoimmune cystitis","volume":"100","author":"Phull","year":"2007","journal-title":"BJU Int."},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"163","DOI":"10.5213\/inj.1734898.449","article-title":"Comparison of 5 Different Rat Models to Establish a Standard Animal Model for Research Into Interstitial Cystitis","volume":"21","author":"Song","year":"2017","journal-title":"Int. Neurourol. J."},{"key":"ref_154","doi-asserted-by":"crossref","unstructured":"Izgi, K., Altuntas, C.Z., Bicer, F., Ozer, A., Sakalar, C., Li, X., Tuohy, V.K., and Daneshgari, F. (2013). Uroplakin peptide-specific autoimmunity initiates interstitial cystitis\/painful bladder syndrome in mice. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0072067"},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"F174","DOI":"10.1152\/ajprenal.00290.2020","article-title":"Autoimmunity to urothelial antigen causes bladder inflammation, pelvic pain, and voiding dysfunction: A novel animal model for Hunner-type interstitial cystitis","volume":"320","author":"Akiyama","year":"2021","journal-title":"Am. J. Physiol.-Ren. Physiol."},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"4120","DOI":"10.21037\/tau-21-392","article-title":"An experimental model of the epithelial to mesenchymal transition and pro-fibrogenesis in urothelial cells related to bladder pain syndrome\/interstitial cystitis","volume":"10","author":"Jin","year":"2021","journal-title":"Transl. Androl. Urol."},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1002\/nau.24240","article-title":"Improving the barrier function of damaged cultured urothelium using chondroitin sulfate","volume":"39","author":"Rozenberg","year":"2020","journal-title":"Neurourol. Urodyn."},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1111\/j.1442-2042.2006.01301.x","article-title":"Toxic factors in human urine that injure urothelium","volume":"13","author":"Rajasekaran","year":"2006","journal-title":"Int. J. Urol."},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1016\/S0022-5347(05)00322-8","article-title":"Botulinum toxin type A inhibits calcitonin gene-related peptide release from isolated rat bladder","volume":"175","author":"Rapp","year":"2006","journal-title":"J. Urol."},{"key":"ref_160","doi-asserted-by":"crossref","unstructured":"Peskar, D., Kuret, T., Jeruc, J., and Erman, A. (2022). Lectins as Biomarkers of IC\/BPS Disease: A Comparative Study of Glycosylation Patterns in Human Pathologic Urothelium and IC\/BPS Experimental Models. Diagnostics, 12.","DOI":"10.3390\/diagnostics12051078"},{"key":"ref_161","doi-asserted-by":"crossref","unstructured":"Horvath, A., Pandur, E., Sipos, K., Micalizzi, G., Mondello, L., Boszormenyi, A., Birinyi, P., and Horvath, G. (2022). Anti-inflammatory effects of lavender and eucalyptus essential oils on the in vitro cell culture model of bladder pain syndrome using T24 cells. BMC Complement. Med., 22.","DOI":"10.1186\/s12906-022-03604-2"},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"887","DOI":"10.3892\/mmr.2014.2823","article-title":"Biological effect of ketamine in urothelial cell lines and global gene expression analysis in the bladders of ketamine-injected mice","volume":"11","author":"Shen","year":"2015","journal-title":"Mol. Med. Rep."},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"30881","DOI":"10.1038\/srep30881","article-title":"Mesenchymal stem cells protect against the tissue fibrosis of ketamine-induced cystitis in rat bladder","volume":"6","author":"Kim","year":"2016","journal-title":"Sci. Rep."},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1111\/j.1464-410X.2009.08847.x","article-title":"Bladder pain syndrome\/interstitial cystitis in a Danish population: A study using the 2008 criteria of the European Society for the Study of Interstitial Cystitis","volume":"105","author":"Richter","year":"2010","journal-title":"BJU Int."},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"2200","DOI":"10.1097\/j.pain.0000000000002616","article-title":"Upregulation of transient receptor potential cation channel subfamily M member-3 in bladder afferents is involved in chronic pain in cyclophosphamide-induced cystitis","volume":"163","author":"Zhao","year":"2022","journal-title":"Pain"},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1080\/14728222.2020.1815191","article-title":"TRPA1 as a therapeutic target for nociceptive pain","volume":"24","author":"Nassini","year":"2020","journal-title":"Expert Opin. Ther. Targets"},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/978-981-16-4254-8_12","article-title":"TRPV1 in Pain and Itch","volume":"1349","author":"Li","year":"2021","journal-title":"Adv. Exp. Med. Biol."},{"key":"ref_168","doi-asserted-by":"crossref","unstructured":"Vanneste, M., Mulier, M., Nogueira Freitas, A.C., Van Ranst, N., Kerstens, A., Voets, T., and Everaerts, W. (2021). TRPM3 Is Expressed in Afferent Bladder Neurons and Is Upregulated during Bladder Inflammation. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23010107"},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"2683","DOI":"10.1111\/bph.14994","article-title":"Functional expression and pharmacological modulation of TRPM3 in human sensory neurons","volume":"177","author":"Vangeel","year":"2020","journal-title":"Br. J. Pharmacol."},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"4687","DOI":"10.2147\/DDDT.S329507","article-title":"Activation of gpr18 by resolvin d2 relieves pain and improves bladder function in cyclophosphamide-induced cystitis through inhibiting trpv1","volume":"15","author":"Lu","year":"2021","journal-title":"Drug Des. Dev. Ther."},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"1791222","DOI":"10.1155\/2021\/1791222","article-title":"Notch1 Signaling Contributes to Mechanical Allodynia Associated with Cyclophosphamide-Induced Cystitis by Promoting Microglia Activation and Neuroinflammation","volume":"2021","author":"Chen","year":"2021","journal-title":"Mediat. Inflamm."},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1002\/nau.24005","article-title":"Neuregulin-1-ErbB signaling promotes microglia activation contributing to mechanical allodynia of cyclophosphamide-induced cystitis","volume":"38","author":"Chen","year":"2019","journal-title":"Neurourol. Urodyn."},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s12974-020-1704-0","article-title":"BDNF promotes activation of astrocytes and microglia contributing to neuroinflammation and mechanical allodynia in cyclophosphamide-induced cystitis","volume":"17","author":"Ding","year":"2020","journal-title":"J. Neuroinflammation"},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.cyto.2018.05.012","article-title":"IL-33 mast cell axis is central in LL-37 induced bladder inflammation and pain in a murine interstitial cystitis model","volume":"110","author":"Jensen","year":"2018","journal-title":"Cytokine"},{"key":"ref_175","first-page":"10","article-title":"Bladder pain in an LL-37 interstitial cystitis and painful bladder syndrome model","volume":"5","author":"Jia","year":"2017","journal-title":"Am. J. Clin. Exp. Urol."},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1111\/his.13235","article-title":"Histopathological characteristics of interstitial cystitis\/bladder pain syndrome without Hunner lesion","volume":"71","author":"Kim","year":"2017","journal-title":"Histopathology"},{"key":"ref_177","doi-asserted-by":"crossref","first-page":"9782","DOI":"10.1038\/s41598-018-28093-7","article-title":"Downregulation of WNT11 is associated with bladder tissue fibrosis in patients with interstitial cystitis\/bladder pain syndrome without Hunner lesion","volume":"8","author":"Choi","year":"2018","journal-title":"Sci. Rep."},{"key":"ref_178","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1111\/j.1365-2559.2010.03640.x","article-title":"YKL-40 and mast cells are associated with detrusor fibrosis in patients diagnosed with bladder pain syndrome\/interstitial cystitis according to the 2008 criteria of the European Society for the Study of Interstitial Cystitis","volume":"57","author":"Richter","year":"2010","journal-title":"Histopathology"},{"key":"ref_179","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1007\/s00192-020-04593-x","article-title":"MicroRNA-495 alleviates ulcerative interstitial cystitis via inactivating the JAK-STAT signaling pathway by inhibiting JAK3","volume":"32","author":"Hou","year":"2021","journal-title":"Int. Urogynecol. J."},{"key":"ref_180","doi-asserted-by":"crossref","first-page":"6429","DOI":"10.1002\/jcb.26610","article-title":"Microrna-139-5p inhibits epithelial-mesenchymal transition and fibrosis in post-menopausal women with interstitial cystitis by targeting LPAR4 via the PI3K\/Akt signaling pathway","volume":"119","author":"Jiang","year":"2018","journal-title":"J. Cell. Biochem."},{"key":"ref_181","doi-asserted-by":"crossref","first-page":"9147","DOI":"10.1002\/jcb.28190","article-title":"Inhibition of microRNA-132 attenuates inflammatory response and detrusor fibrosis in rats with interstitial cystitis via the JAK-STAT signaling pathway","volume":"120","author":"Song","year":"2019","journal-title":"J. Cell. Biochem."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/23\/23\/14594\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T01:25:02Z","timestamp":1760145902000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/23\/23\/14594"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,23]]},"references-count":181,"journal-issue":{"issue":"23","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["ijms232314594"],"URL":"https:\/\/doi.org\/10.3390\/ijms232314594","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,23]]}}}